Prevention of renal injury and endothelial dysfunction by chronic l-arginine and antioxidant treatment

Renal Failure

Volumn 33, Issue 1, 2011, Pages 47-53

  Arellano Mendoza, Monica G ^a   Vargas Robles, Hilda ^b   Del Valle Mondragon, Leonardo ^c   Rios, Amelia ^b   Escalante, Bruno ^b  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c Instituto Nacional de Cardiologa Ignacio Chvez   (Mexico)

Author keywords

Antioxidants; Endothelial dysfunction; Kidney failure; Nitric oxide; Reactive oxygen species

Indexed keywords

ALPHA TOCOPHEROL; ARGININE; ASCORBIC ACID; DIHYDROBIOPTERIN; MESSENGER RNA; NITRIC OXIDE SYNTHASE; TETRAHYDROBIOPTERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; MALE; MOUSE; NEPHRECTOMY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RENAL PROTECTION; SURVIVAL RATE;

ANIMALS; ANTIOXIDANTS; ARGININE; ASCORBIC ACID; ENDOTHELIUM; MALE; MICE; RENAL INSUFFICIENCY; VITAMIN E; VITAMINS;

EID: 78651328545     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2010.541583     Document Type: Article

References (34)

1. Persson PB. Nitric oxide in the kidney. Am J Physiol regul Integr Comp Physiol. 2002;283:R1005-R1007.
2. Mattson DL, Lu S, Nakanishi K, Papanek PE, Cowley AW, Jr. Effects of chronic renal medullary nitric oxide inhibition on blood pressure. Am J Physyiol. 1994;266:H1918-H1926.
3. Aiello S, Noris M, Todeschini M, et al. Renal and systemic nitric oxide in rats with renal mass reduction. Kidney Int. 1997;52:171-181.
4. Conger J, Robinnette J, Villar A. Increased nitric oxide synthase activity despite lack of response to endothelium-dependent vasodilatation in post ischemic acute renal failure in rats. J Clin Invest. 1995;96:631-638.
5. Baylis C. Nitric oxide deficiency in chronic kidney disease. Am J Physiol. 2008;294:F1-F9.
6. Arellano Mendoza MG, Castillo Henkel C, Medina Santillan R et al. Kidney damage after renal ablation is worsened in endothelial nitric oxide synthase (-/-) mice and improved by combined administration of L-Arginine and antioxidants. Nephrology. 2008;13:218-227.
7. Mimic-Oka J, Simic T, Djukanovic L. Alteration in plasma antioxidant capacity in various degree of chronic renal failure. Clin Nephrol. 1999;51:233-241.
8. Tain YL, Freshour G, Dikalova A, Griendling K, Baylis, C. Vitamin E reduces glomerulosclerosis, restores renal neuronal NOS and suppresses oxidative stress in the 5/6 nephrectomized rat. Am J Physiol Renal Physiol. 2007;292:F1404-F1410.
9. Hasdan G, Benchetrit S, Rashid G, Green J, Bernheim J, Rathaus M. Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxide. Kidney Int. 2002;61:586-590.
10. Modlinger PS, Wilcox CS, Aslam S. Nitric oxide, oxidative stress and progression of chronic renal failure. Semin Nephrol. 2004;24:354-365.
11. Katoh T, Takohashi K, Klahr S, Reyes AA, Badr KF. Dietary supplementation with L-arginine ameliorates glomerular hypertension in rats with subtotal nephrectomy. J Am Soc Nephrol. 1994;4:1690-1694.
12. Reyes AA, Karl IE, Kissane J, Klahr S. L-arginine administration prevents glomerular hyperfiltration and decreases proteinuria in diabetic rats. J Am Soc Nephrol. 1993;4: 1039-1045.
13. De Nicola L, Thomson SC, Wead LM, Brown MR, Gabbai FB. Arginine feeding modifies cyclosporine nephrotoxicity in rats. J Clin Invest. 1993;92:1859-1865.
14. Kashihara N, Satoh M. Molecular pathogenesis of chronic kidney disease. Nippon Rinsho. 2008;66:1671-1677.
15. Sucher R, Gehwolf P, Oberhuber R, et al. Tetrahydrobiop-terin protects the kidney from ischemia reperfusion injury. Kidney Int. 2010;77:681-689. Epub 2010 Feb 17.
16. Yamamizu K, Shinozozaki K, Ayajiki K, Gemba M, Okamura T. Oral administration of both tetrahydrobiopterin and L-arginine prevents endothelial dysfunction in rats with chronic renal failure. J Cardiovscular Pharmacol. 2007;49:131-139.
17. Korish AA. Oxidative stress and nitric oxide deficiency in inflammation of chronic renal failure. Possible preventive role of L-arginine and multiple antioxidants. Saudi Med J. 2009;30: 1150-1157.
18. Wuhl E, Schaefer F. Therapeutic strategies to slow chronic kidney disease progression. Pediatr Nephrol. 2008;23:705-716.
19. Coronel I, Arellano-Mendoza MG, Del Valle-Mondragon L, et al. L-arginine and antioxidant diet supplementation partially restores nitric oxide dependent regulation of phenylephrine renal vasoconstriction in diabetic rats. J Ren Nutr. 2010;20: 158-168.
20. Griffin KA, Picken M, Bidani AK. Method of renal mass reduction is a critical modulator of subsequent injury and hypertension. J Am Soc Nephrol. 1994;4:2023-2031.
21. Bradford MM. A rapid and sensitive method for the quantization of microgram quantities of protein utilizing the principle of protein dye binding. Ann Biochem. 1976;72:248-254.
22. Han F, Huynh BH, Shi H, Lin B, Ma Y. Pteridine analysis in urine by capillary electrophoresis using laser-induced fluorescence detection. Anal Chem. 1999;71:1265-1269.
23. Livak KJ, Schmittgen TD. Analysis of relative gene expression real-time quantitative PCR and the 2(-Delta Delta C (T)) Method. Methods. 2001;25:402-408.
24. Miller FJ, Jr, Gulterman DD, Rios CD, Heistad DD, Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res. 1998;82:1298-1305.
25. Rothe G, Valet G. Flow cytometric analysis of respiratory bursa activity in phagocytes whit hydroethidium and 2′,7′dichlorofluorescein. J Leukoc Biol. 1995;55:253-258.
26. Van Dokkum RP, Jacob HJ, Provoost AP. Genetic differences define severity of renal damage after L-NAME induced hypertension in rats. J Am Soc Neprhol. 1998;9:363-371.
27. Robertso JL, Goldschmidt M, Kronfeld DS, Tomaszewski JE, Hill GS, Bovee KC. Long-term renal responses to high dietary protein in dogs with 75% nephrectomy. Kidney Int. 1986; 29:511-519.
28. Wuhl E, Schaefer F. Can we slow the progression of chronic kidney disease? Curr Opin Pediatr. 2010;22:170-175.
29. Ashab I, Peer G, Blum M, et al. Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production. Kidney Int. 1995;47:1515-1521.
30. Huang A, Vita JA, Venema RC, Keaney JF, Jr. Ascorbic acid enhances endothelial nitric oxide synthase activity by increasing intracellular tetrahydrobiopterin. J Biol Chem. 2000;275: 17399-17406.
31. Baker TA, Milstien S, Katsic ZS. Effect of vitamin C on the availability of tetrahydrobiopterin in human endothelial cells. J Cardiovasc Pharmacol. 2001;37:333-338.
32. Okon EB, Chung AWY, Rauniyar P, et al. Compromised arterial function in human type 2 diabetic patients. Diabetes. 2005;54:2415-2423.
33. Guzik TJ, Mussa S, Gastaldi D, et al. Mechanism of increased vascular superoxide production in human diabetes mellitus: role of NADPH oxidase and endothelial nitric oxide synthase. Circulation. 2002;105:1656-1662.
34. Settergreen M, Bohn F, Malmstrom RE, Channon KM, Pemow J. L-arginine and tetrahydrobiopterin protects against ischemia/reperfusion-induced endothelial dysfunction in patients with type 2 diabetes mellitus and coronary artery disease. Atherosclerosis. 2009;204:73-78.